These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33382970)

  • 1. From astrocytes to satellite glial cells and back: A 25 year-long journey through the purinergic modulation of glial functions in pain and more.
    Ceruti S
    Biochem Pharmacol; 2021 May; 187():114397. PubMed ID: 33382970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The purinergic system and glial cells: emerging costars in nociception.
    Magni G; Ceruti S
    Biomed Res Int; 2014; 2014():495789. PubMed ID: 25276794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain.
    Donnelly CR; Andriessen AS; Chen G; Wang K; Jiang C; Maixner W; Ji RR
    Neurotherapeutics; 2020 Jul; 17(3):846-860. PubMed ID: 32820378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adenosine and P2Y receptors expressed by multiple cell types in pain transmission.
    Magni G; Ceruti S
    Brain Res Bull; 2019 Sep; 151():132-143. PubMed ID: 30797817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tackling Chronic Pain and Inflammation through the Purinergic System.
    Magni G; Riccio D; Ceruti S
    Curr Med Chem; 2018; 25(32):3830-3865. PubMed ID: 28699505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinergic signaling in diabetes and metabolism.
    Jain S; Jacobson KA
    Biochem Pharmacol; 2021 May; 187():114393. PubMed ID: 33359363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.
    Lecca D; Ceruti S; Fumagalli M; Abbracchio MP
    Purinergic Signal; 2012 Sep; 8(3):539-57. PubMed ID: 22528683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinoceptors on neuroglia.
    Verkhratsky A; Krishtal OA; Burnstock G
    Mol Neurobiol; 2009 Jun; 39(3):190-208. PubMed ID: 19283516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic signalling in the kidney: In physiology and disease.
    Monaghan MT; Bailey MA; Unwin RJ
    Biochem Pharmacol; 2021 May; 187():114389. PubMed ID: 33359067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of purinergic receptors in CNS function and neuroprotection.
    Tozaki-Saitoh H; Tsuda M; Inoue K
    Adv Pharmacol; 2011; 61():495-528. PubMed ID: 21586368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial Modulation as a Target for Chronic Pain: From the Bench to the Bedside and Back.
    Haight ES; Forman TE; Cordonnier SA; James ML; Tawfik VL
    Anesth Analg; 2019 Apr; 128(4):737-746. PubMed ID: 30883419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purines and sensory nerves.
    Burnstock G
    Handb Exp Pharmacol; 2009; (194):333-92. PubMed ID: 19655112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous purinergic signaling is required for osmotic volume regulation of retinal glial cells.
    Wurm A; Lipp S; Pannicke T; Linnertz R; Krügel U; Schulz A; Färber K; Zahn D; Grosse J; Wiedemann P; Chen J; Schöneberg T; Illes P; Reichenbach A; Bringmann A
    J Neurochem; 2010 Mar; 112(5):1261-72. PubMed ID: 20002522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic neuron-glia interactions in sensory systems.
    Lohr C; Grosche A; Reichenbach A; Hirnet D
    Pflugers Arch; 2014 Oct; 466(10):1859-72. PubMed ID: 24705940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Purine analgesia: experimental results and clinical perspectives].
    Karelov AE
    Anesteziol Reanimatol; 2010; (5):86-9. PubMed ID: 21395150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic Mechanisms and Pain.
    Burnstock G
    Adv Pharmacol; 2016; 75():91-137. PubMed ID: 26920010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives in Pain Research 2014: Neuroinflammation and glial cell activation: The cause of transition from acute to chronic pain?
    Cairns BE; Arendt-Nielsen L; Sacerdote P
    Scand J Pain; 2015 Jan; 6(1):3-6. PubMed ID: 29911589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain.
    Ruiz-Cantero MC; González-Cano R; Tejada MÁ; Santos-Caballero M; Perazzoli G; Nieto FR; Cobos EJ
    Pharmacol Res; 2021 Jan; 163():105339. PubMed ID: 33276102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic signalling in host innate immune defence against intracellular pathogens.
    Coutinho-Silva R; Savio LEB
    Biochem Pharmacol; 2021 May; 187():114405. PubMed ID: 33406411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y purinergic receptors: new targets for analgesic and antimigraine drugs.
    Magni G; Ceruti S
    Biochem Pharmacol; 2013 Feb; 85(4):466-77. PubMed ID: 23146663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.